2.16.840.1.113883.5.1070: Unterschied zwischen den Versionen

Aus Hl7wiki
Wechseln zu: Navigation, Suche
(Automated TermBot page content)
 
(Automated TermBot page content)
 
Zeile 32: Zeile 32:
 
Manuelle Änderungen dieser Seite sind daher wirkungslos.
 
Manuelle Änderungen dieser Seite sind daher wirkungslos.
 
***************************
 
***************************
-->
+
-->* [[2.16.840.1.113883.1.11.16621]] ActSubstanceAdminSubstitutionCode (2012-07-24)
 +
 
 
==Zusammenstellung aller Versionen dieses Kodesystems==
 
==Zusammenstellung aller Versionen dieses Kodesystems==
 
<!--
 
<!--
Zeile 39: Zeile 40:
 
Manuelle Änderungen dieser Seite sind daher wirkungslos.
 
Manuelle Änderungen dieser Seite sind daher wirkungslos.
 
***************************
 
***************************
-->(bisher keine weiteren Angaben)
+
-->* [[2.16.840.1.113883.5.1070/static-2012-07-24|2012-07-24]]

Aktuelle Version vom 11. November 2012, 18:48 Uhr

Hinweis zu dieser Seite

Kodesystem substanceAdminSubstitution

Beschreibung

Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.

Aktuelle Version

Codesystem Name Codesystem Id Version / Eingangsdatum Status
substanceAdminSubstitution 2.16.840.1.113883.5.1070 2012-07-24 definitiv
Level/Typ Code Anzeigename Beschreibung
0-A _ActSubstanceAdminSubstitutionCode EN-US.png ActSubstanceAdminSubstitutionCode

Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.

1-S E EN-US.png equivalent

Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.

2-S EC EN-US.png equivalent composition

Description: Substitution occurred or is permitted with another product that is a: pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration Examples: Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate Pharmaceutical equivalent: Lisonpril for Zestril

3-L BC EN-US.png brand composition

Description: Substitution occurred or is permitted between equivalent Brands but not Generics Examples: Zestril for Prinivil Coumadin for Jantoven

3-L G EN-US.png generic composition

Description: Substitution occurred or is permitted between equivalent Generics but not Brands Examples: Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)

2-S TE EN-US.png therapeutic alternative

Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile. Examples: ranitidine for Tagamet

3-L TB EN-US.png therapeutic brand

Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics> Examples: Zantac for Tagamet

3-L TG EN-US.png therapeutic generic

Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands> Examples: Ranitidine for cimetidine

1-L F EN-US.png formulary

Description: This substitution was performed or is permitted based on formulary guidelines.

1-L N EN-US.png none

No substitution occurred or is permitted.

Verwendung in Value Sets

Zusammenstellung aller Versionen dieses Kodesystems